LY3076226

· Eli Lilly and Company

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for LY3076226, covering 2020-04-17 to 2020-04-17. Get the full timeline:

Most recent: Clinical Trial Update: A Study of LY3076226 in Participants With Advanced or Metastatic Cancer [Phase 1]